Episode Details
Back to Episodes
U.S. Cannabis Market Faces Price Pressure but Eyes Growth Through 2026 Expansion
Published 3 weeks, 6 days ago
Description
In the past 48 hours, the U.S. cannabis industry shows modest growth amid price pressures and strategic expansions. Whitney Economics projects 2026 sales at 30.5 billion dollars, up 4.9 percent from 2025s 29.1 billion, down from 2024s 30.1 billion, driven by retail gains in New York and New Jersey but offset by compression in California, where 2025 sales fell 7.1 percent to 3.9 billion despite higher unit sales.[1]
Key partnerships emerged: On March 31, Bloom expanded with Cresco Labs to launch vape products in Pennsylvanias medical market, leveraging Crescos dispensary network.[2] Curaleaf opened a branded dispensary in Lorain, Ohio, on March 31, partnering with RC Retail to reach 164 nationwide locations, with a grand opening set for April 10.[6] International Star Inc. advanced deals via Budding Equity, including Nevada manufacturing with Premium Produce and Thailand licensing for Fryday and Da Grassy brands.[4]
New Yorks market hit 250 million dollars in the first seven weeks of 2026, on pace for 2.6 billion annually, up from 1.6 billion in 2025, with total adult-use sales at 3.3 billion over five years; officials eye 4.5 billion by 2028.[5] Federal shifts loom, as the 2025 Continuing Appropriations Act will redefine hemp in November 2026, potentially curbing intoxicating products and boosting legal sales in states like Nevada.[3]
Leaders respond proactively: Curaleaf expands footprints amid uncertainty, while 1933 Industries reports Q2 2026 revenue of 7.9 million dollars and eyes hemp regulation relief.[3] Compared to prior weeks, growth slowed from forecasted 13.4 percent, reflecting consumer pullback and illicit competition, but equity funding like New Yorks 17 million injection signals resilience.[1][5] No major disruptions reported, though Ohio faces hemp beverage legal fights.[10] Overall, consolidation and compliance define the sectors steady navigation of headwinds. (298 words)
For great deals today, check out https://amzn.to/44ci4hQ
This content was created in partnership and with the help of Artificial Intelligence AI
Key partnerships emerged: On March 31, Bloom expanded with Cresco Labs to launch vape products in Pennsylvanias medical market, leveraging Crescos dispensary network.[2] Curaleaf opened a branded dispensary in Lorain, Ohio, on March 31, partnering with RC Retail to reach 164 nationwide locations, with a grand opening set for April 10.[6] International Star Inc. advanced deals via Budding Equity, including Nevada manufacturing with Premium Produce and Thailand licensing for Fryday and Da Grassy brands.[4]
New Yorks market hit 250 million dollars in the first seven weeks of 2026, on pace for 2.6 billion annually, up from 1.6 billion in 2025, with total adult-use sales at 3.3 billion over five years; officials eye 4.5 billion by 2028.[5] Federal shifts loom, as the 2025 Continuing Appropriations Act will redefine hemp in November 2026, potentially curbing intoxicating products and boosting legal sales in states like Nevada.[3]
Leaders respond proactively: Curaleaf expands footprints amid uncertainty, while 1933 Industries reports Q2 2026 revenue of 7.9 million dollars and eyes hemp regulation relief.[3] Compared to prior weeks, growth slowed from forecasted 13.4 percent, reflecting consumer pullback and illicit competition, but equity funding like New Yorks 17 million injection signals resilience.[1][5] No major disruptions reported, though Ohio faces hemp beverage legal fights.[10] Overall, consolidation and compliance define the sectors steady navigation of headwinds. (298 words)
For great deals today, check out https://amzn.to/44ci4hQ
This content was created in partnership and with the help of Artificial Intelligence AI